L Brands, Inc (LB) Stock Price

68.73 ▲ +0.03 (+0.04%)
Open: 67.66 Vol: 419.12K Day's range: 66.07 - 69.79 Apr 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY NEUTRAL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 69.09▼ 68.35▲ 68.17▲ 68.55▲ 68.30▲
MA10 68.86▼ 67.99▲ 68.40▲ 68.20▲ 70.61▼
MA20 68.53▲ 68.44▲ 68.75▼ 68.10▲ 63.93▲
MA50 67.99▲ 68.90▼ 68.59▲ 70.17▼ 61.56▲
MA100 68.50▲ 68.52▲ 68.16▲ 62.71▲ 60.20▲
MA200 68.91▼ 68.04▲ 68.99▼ 59.65▲ 46.39▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.032▲ 0.085▲ -0.089▼ 0.132▲ 0.145▲
RSI 53.673▲ 51.212▲ 49.956▼ 50.366▲ 55.104▲
STOCH 75.996     77.603     43.824     60.851     49.310    
WILL %R -71.200     -35.571     -56.383     -45.220     -41.406    
CCI 12.201     130.615▲ 1.937     0.387     19.456    
Latest Filters Detected On LB
▲ RSI&VOL $LB RSI Cross Up and Volume Set Alert
RSI $LB RSI(14) Crossed Above 50 Set Alert
MA $LB Price Crossed Above MA(26) Set Alert
MA $LB Price Crossed Above MA(13) Set Alert
MA $LB Price Crossed Above MA(7) Set Alert
CDL $LB Harami Candlestick Pattern Detected Set Alert
L Brands, Inc News
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
Wednesday, April 22, 2026 04:47 PM
Pivotal Phase 3 NOVA-2 trial in schizophrenia ongoing, topline data expected in 2H 2027LB-102 has potential to be the first benzamide approved ...
LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham
Thursday, April 16, 2026 07:32 PM
LB Pharmaceuticals (NASDAQ:LBRX) is seeking to build a “fully integrated company focused on CNS-related diseases,” Chief Executive Officer Heather Turner said during a presentation at a Needham ...
Missionirnewsbreaks LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 As Novel Approach In Cancer Treatment Landscape
Thursday, April 16, 2026 07:03 PM
Positions LB-100 As Novel Approach In Cancer Treatment Landscape. Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of ...
LB historical stock data
date open high low close volume
30/04/26 67.66 69.79 66.07 68.73 419,118
29/04/26 69.08 71.71 68.57 68.70 263,662
28/04/26 70.26 70.8599 67.81 67.93 86,645
27/04/26 68.74 70.4699 68.74 69.11 104,381
24/04/26 69.66 69.99 67.1301 68.29 129,600
23/04/26 67.80 70.44 67.16 69.66 169,282
22/04/26 67.78 68.715 67.24 67.84 89,809
21/04/26 67.95 68.60 66.71 66.74 134,544
20/04/26 67.38 67.99 66.205 67.74 165,585
17/04/26 66.82 67.9648 65.12 67.23 289,005
Quote Details
52wk Low:43.75
52wk High:87.597
Vol:419.12K
Avg Vol(3m):9M
1Y Chng:-18.66%
1M Chng:-3.27%
Add to Watch List
More Information
Index N/A
Market Cap. 5.47B